Thieno[2,3-c]pyrrol-4-one derivatives as erk inhibitors
The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.
Saved in:
| Main Authors | , , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
21.12.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer. |
|---|---|
| AbstractList | The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer. |
| Author | Cortez, Guillermo S Joseph, Sajan Rodriguez, Michael John Mclean, Johnathan Alexander Zhao, Gaiying Mcmillen, William T |
| Author_xml | – fullname: Zhao, Gaiying – fullname: Joseph, Sajan – fullname: Mcmillen, William T – fullname: Rodriguez, Michael John – fullname: Mclean, Johnathan Alexander – fullname: Cortez, Guillermo S |
| BookMark | eNrjYmDJy89L5WQwD8nITM3LjzbSMdZNji2oLCrKz9E10QXKKaSkFmWWJZZklqUWKyQWK6QWZStk5mVkJmWW5BcV8zCwpiXmFKfyQmluBjk31xBnD93Ugvz41OKCxOTUvNSSeL8oc2NDU2NDR2OCCgB1sy37 |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | NZ731531A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_NZ731531A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:16:30 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_NZ731531A3 |
| Notes | Application Number: NZ20150731531 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181221&DB=EPODOC&CC=NZ&NR=731531A |
| ParticipantIDs | epo_espacenet_NZ731531A |
| PublicationCentury | 2000 |
| PublicationDate | 20181221 |
| PublicationDateYYYYMMDD | 2018-12-21 |
| PublicationDate_xml | – month: 12 year: 2018 text: 20181221 day: 21 |
| PublicationDecade | 2010 |
| PublicationYear | 2018 |
| RelatedCompanies | ELI LILLY AND COMPANY |
| RelatedCompanies_xml | – name: ELI LILLY AND COMPANY |
| Score | 3.178784 |
| Snippet | The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Thieno[2,3-c]pyrrol-4-one derivatives as erk inhibitors |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181221&DB=EPODOC&locale=&CC=NZ&NR=731531A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LS8NAEB5qFfWm9f0oOUhOLprNyxyC2KSlCE2LVCkVKXlMbFCSkkTFf-9sSNVLb8suDLPDfjs7Oy-AC4xD0cQCmYGRzjQrjpnvRz4L0bzG0DJ4gMKjO_CM_qN2P9EnDXhd5sJUdUK_quKIhKiQ8F5W9_Xi7xPLrWIri6sgoanstje2Xbm2joW64orsduzuaOgOHdlxbG8qew-2qRK0lbs1WKc3tCmg0H3qiJSUxX990tuBjRGRSstdaGDagi1n2XatBZuD2ttNwxp4xR6Y4zkNs2d-qbLwZfGd59k701iWohTRGfqsyncXkl9ImL9JSTpPgkT00dmHdq87dvqMOJj97nXmTWtO1QNopkTlCCQ0NANvULXQt8i-QJ_rgaJFaPHA5HFsHcPhCiInK1dOYVuISwRmcOUMmmX-geekXsugXYnmB5YqgWg |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7Uaqw3re9H5WA4uVEWCnIgxkKbqi1tDJqmxhAegyUaaAA1_nt3CVUvvW12k8nsZL-dnZ0XwBlGAW9igUTFsE0UPYqI54UeCVC7xEBXqY_cozu01f6jcjdpT2rwusiFKeuEfpXFERmiAob3oryv53-fWFYZW5lf-DGbSq97jmGJlXXM1RWVRKtjdMcja2SKpmnYU9F-MDSZQVu6WYFV9r7WOBS6Tx2ekjL_r096m7A2ZqSSYgtqmDShYS7arjVhfVh5u9mwAl6-DZozY8P0mZ7LJHiZf2dZ-k4UkiYohOwMfZblu3PBywXM3oQ4mcV-zPvo7ECr13XMPmEcuL97de1pxam8C_WEUdkHAVVFxSuUdfR0Zl-gR9u-pISoU1-jUaQfwN4SIodLV06h0XeGA3dwa98fwQYXHQ_SoNIx1IvsA0-Yqi38VimmH9LZhFs |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Thieno%5B2%2C3-c%5Dpyrrol-4-one+derivatives+as+erk+inhibitors&rft.inventor=Zhao%2C+Gaiying&rft.inventor=Joseph%2C+Sajan&rft.inventor=Mcmillen%2C+William+T&rft.inventor=Rodriguez%2C+Michael+John&rft.inventor=Mclean%2C+Johnathan+Alexander&rft.inventor=Cortez%2C+Guillermo+S&rft.date=2018-12-21&rft.externalDBID=A&rft.externalDocID=NZ731531A |